檢索結果 - Bob Wilffert
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Association between Adherence to Guideline-Recommended Preventive Medications and In-Hospital Mortality among Non-Reperfused ST-Elevation Myocardial Infarction Patients Admitted to... 由 Sylvi Irawati, Surya Dharma, Katja Taxis, Thắng Nguyễn, Nunung Nursyarofah, Bob Wilffert, Eelko Hak
出版 2020Artigo -
8
-
9
-
10
-
11
-
12
-
13
-
14
P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study 由 Nur Aizati Athirah Daud, Jorieke E. H. Bergman, Marian K. Bakker, Hao Wang, Wilhelmina S. Kerstjens‐Frederikse, Hermien E. K. de Walle, Henk Groen, Jens H. J. Bos, Eelko Hak, Bob Wilffert
出版 2015Artigo -
15
Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients 由 Innokentiy S. Losenkov, Nathaniël J. V. Mulder, Л. А. Левчук, N. Vyalova, A.J.M. Loonen, Fokko J. Bosker, Г. Г. Симуткин, Anastasiia S. Boiko, Н. А. Бохан, Bob Wilffert, Eelko Hak, Amand F. Schmidt, Svetlana А. Ivanova
出版 2020Artigo -
16
NMDA receptor genotypes associated with the vulnerability to develop dyskinesia 由 Svetlana А. Ivanova, A.J.M. Loonen, Petros Pechlivanoglou, Maxim B. Freidin, A.F.Y. Al Hadithy, E.V. Rudikov, Irina Zhukova, Н. В. Говорин, В.А. Сорокина, Olga Fedorenko, В. М. Алифирова, A. Semke, J. R. B. J. Brouwers, Bob Wilffert
出版 2012Artigo -
17
Pharmacogenetic Information in Clinical Guidelines: The European Perspective 由 Jesse J. Swen, Marga Nijenhuis, Mandy van Rhenen, Nienke J. de Boer‐Veger, Anne‐Marie Buunk, Elisa J. F. Houwink, Hans Mulder, Gerard A. Rongen, Ron H. N. van Schaik, Jan van der Weide, Bob Wilffert, Vera H.M. Deneer, Henk‐Jan Guchelaar
出版 2018Revisão -
18
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone) 由 Maja Matić, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer‐Veger, Anne‐Marie Buunk, Elisa J. F. Houwink, Hans Mulder, Gerard A. Rongen, Jan van der Weide, Bob Wilffert, Jesse J. Swen, Henk‐Jan Guchelaar, Vera H.M. Deneer, Ron H. N. van Schaik
出版 2021Artigo -
19
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs 由 J. Brouwer, Marga Nijenhuis, Bianca Soree, Henk‐Jan Guchelaar, Jesse J. Swen, Ron H. N. van Schaik, Jan van der Weide, Gerard A. Rongen, Anne‐Marie Buunk, Nienke J. de Boer‐Veger, Elisa J. F. Houwink, Roos van Westrhenen, Bob Wilffert, Vera H.M. Deneer, Hans Mulder
出版 2021Artigo -
20
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines 由 Carin A.T.C. Lunenburg, Cathelijne H. van der Wouden, Marga Nijenhuis, Mandy H. Crommentuijn-van Rhenen, Nienke J. de Boer‐Veger, Anne M. Buunk, Elisa J. F. Houwink, Hans Mulder, Gerard A. Rongen, Ron H. N. van Schaik, Jan van der Weide, Bob Wilffert, Vera H.M. Deneer, Jesse J. Swen, Henk‐Jan Guchelaar
出版 2019Artigo
相關主題
Medicine
Internal medicine
Biology
Pharmacology
Gene
Genotype
Pathology
Pharmacogenetics
Genetics
Drug
Pharmacogenomics
Psychiatry
Antidepressant
CYP2D6
Pharmacokinetics
Psychology
Tuberculosis
Biochemistry
Chemistry
Cytochrome P450
Economics
Guideline
Intensive care medicine
Metabolism
Oncology
Receptor
Anxiety
CYP2C19
CYP2C9
Cancer